Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 517 Telecommunications |
Additional NAICS Codes | 541714 |
Address | 200 Sidney Street Cambridge, MA 02139 sereshealth.com |
Seres Therapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Date | Investors | Percent Raised | Target Size |
---|---|---|---|
January 5, 2015 | 1 | 100% | $65 MM |
Complete list of funding rounds and total amounts in the Company Report |
Trademark | Date |
---|---|
VOWST VOYAGE Educational services, namely, conducting educational programs in the fields of dysbiosis and other medical conditions resulting from a disturbed microbial community and treatment and patient support options for these conditions | 03/08/2023 |
CDOWST Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community | 10/14/2020 |
CDRUPTEV Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, namely, for the treatment of dysbiosis and clostridium difficile; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent and treat dysbiosis and other medical conditions resulting from a disturbed microbial community | 10/14/2020 |
Publisher: AnythingResearch
Company | Headquarters | Revenue ($ MM) |
---|---|---|
AT & T | Dallas, TX | 100 |
VERIZON COMMUNICATIONS | New York, NY | 57 |
CCO HOLDINGS | Saint Louis, MO | 55 |
T-MOBILE USA | Bellevue, WA | 46 |
QUALCOMM | San Diego, CA | 34 |
DIRECTV | El Segundo, CA | 34 |
LUMEN TECHNOLOGIES | Monroe, LA | 15 |
NATIONAL TELECOMMUNICATIONS COOPERATIVE ASSOCIATION | Arlington, VA | 13 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
GRANITE TELECOMMUNICATIONS | Quincy, MA | 100 |
SERES THERAPEUTICS | Cambridge, MA | 21 |
STARRY | Boston, MA | 10 |
COMNISCIENT TECHNOLOGIES | Boston, MA | 8 |
TIVE | Charlestown, MA | 5 |
ALTAEROS ENERGIES | Somerville, MA | 2 |
Company | Revenue ($ MM) |
---|---|
|